Selenium as a therapeutic adjuvant for isoniazid/rifampicin-induced hepatotoxicity

• Váldodahkkit: Elias Adikwu (Dahkki), Ebinyo Clemente Nelson (Dahkki), Peter Fiyebo (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BACKGROUND: Isoniazid-rifampicin (INH-RIF) is used for the treatment of tuberculosis, but its hepatotoxicity is a serious health predicament. Selenium (Se) is a trace element with potential to safeguard cells from damage. AIM AND OBJECTIVE: This study assessed the potential of Se to prevent INH/RIF-...